Top Institutions in Ophthalmology
Leading institutions in ophthalmology and retinal disease research have conducted randomized controlled trials and translational studies on PBM and mitochondrial function in retinal cells, combining clinical trial expertise with advanced imaging and molecular biology techniques to evaluate efficacy and mechanisms.
-
#1
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is a world leader in retinal disease research and clinical trials, with extensive expertise in AMD and novel therapies including photobiomodulation, supported by strong translational research programs.
Key Differentiators
- Ophthalmology
- Retinal Diseases
- Clinical Trials
-
#2
Massachusetts Eye and Ear Infirmary, Harvard Medical School
Boston, MA
Known for pioneering retinal imaging and neurodegenerative eye disease research, Mass Eye and Ear has contributed significantly to understanding AMD pathophysiology and emerging treatments like PBM.
Key Differentiators
- Ophthalmology
- Retinal Imaging
- Neuro-ophthalmology
-
#3
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is renowned for its comprehensive research in retinal degenerations and clinical trial expertise, including studies on mitochondrial-targeted therapies and light-based treatments.
Key Differentiators
- Ophthalmology
- Retinal Degeneration
- Clinical Research
-
#4
University of California, San Francisco (UCSF) Department of Ophthalmology
San Francisco, CA
UCSF has a strong translational research program bridging basic mitochondrial biology with clinical applications in retinal diseases, including innovative therapies such as photobiomodulation.
Key Differentiators
- Ophthalmology
- Retinal Disease
- Translational Medicine
-
#5
Moorfields Eye Hospital and UCL Institute of Ophthalmology
London, N/A
Moorfields and UCL are leading centers for retinal disease research in Europe, with expertise in AMD clinical trials and emerging therapies including light-based and mitochondrial-targeted treatments.
Key Differentiators
- Ophthalmology
- Retinal Research
- Clinical Trials
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







